封面
市场调查报告书
商品编码
1550667

全球生命科学 BPO 市场:依服务类型、最终用户、地区

Life Sciences BPO Market, By Service Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球生命科学 BPO 市场规模预计将从 2024 年的 4,081 亿美元增加到 2031 年的 9,722 亿美元,2024 年至 2031 年复合年增长率为 13.2%。

报告范围 报告详情
基准年 2023年 2024年市场规模 4081亿美元
实际资料 2019-2023 预测期 2024-2031
预测 2024-2031 年复合年增长率: 13.20% 2031年价值预测 9722亿美元
图:2024 年生命科学 BPO 市场占有率(按地区划分)
生命科学 BPO 市场-IMG1

生命科学 BPO 市场由向医疗保健产业提供的外包服务组成,包括製药公司、生技公司和医疗设备公司。我们帮助生命科学公司专注于药物发现、产品开发和商业化的核心业务。监管事务管理、临床资料管理、医学写作和出版、药物安全检测、医学监测和其他临床试验相关服务等服务委託给专业的 BPO 提供者。成本优化、先进基础设施和专业知识的获取、复杂的法律规范以及简化业务的需求等因素正在增加生命科学领域的外包。

市场动态:

全球生命科学 BPO 市场的成长是由生命科学公司不断增长的成本优化需求以及 BPO服务供应商提供的先进基础设施和专业知识带来的好处所推动的。此外,药物开发和核准的法律规范逐年变得更加复杂,因此有必要外包非核心职能。医疗保健产业动态的变化,例如向基于价值的照护的转变,也促使生命科学公司透过策略性外包来简化业务。然而,资料安全问题、关键功能失控以及与供应商管理相关的营运挑战等因素可能会阻碍市场成长。新兴市场医疗保健支出的增加、生物相似药和基因组药物的开发以及人工智慧/区块链的整合以增强 BPO 服务可能为市场成长提供机会。

本研究的主要特点

该报告对全球生命科学 BPO 市场进行了详细分析,并以 2023 年为基准年估计了预测期内(2024-2031 年)的市场规模(十亿美元)和年复合成长率(CAGR%)。发布。

它还揭示了各个细分市场的潜在商机,并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、关键亮点、绩效和策略等参数对全球生命科学 BPO 市场的主要企业进行了分析。

本研究涵盖的主要企业包括 Cognizant、Accenture、简柏特、EXL services、康泰伦特等。

该报告的见解将帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球生命科学 BPO 市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球生命科学 BPO 市场的各种策略矩阵,将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球生命科学 BPO 市场 - 新冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球生命科学 BPO 市场:依服务类型(2019-2031)

  • 医药外包
  • API
  • 完整剂型
  • 包装
  • 药物发现
  • 临床前研究
  • 临床试验研究
  • 监管服务
  • 药物警戒
  • 医疗设备外包
  • 电子设备製造服务
  • 成品
  • 原料/零件
  • 监理咨询服务
  • 产品设计及开发服务
  • 产品测试服务
  • 产品实施服务
  • 产品升级服务
  • 产品维修服务
  • 合约销售和市场外包
  • 其他的

第六章全球生命科学 BPO 市场:依最终使用者分类(2019-2031)

  • 製药公司
  • 生技公司
  • 合约研究组织
  • 医疗设备公司
  • 学术和政府机构

第七章全球生命科学 BPO 市场:按地区(2019-2031)

  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东

第八章 竞争格局

  • 公司简介
    • Accenture, Plc
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab Biotechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

第九章 分析师建议

  • Wheel of Fortune
  • 分析师观点
  • Coherent Opportunity Map(COM)

第10章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI24

Global life sciences BPO market is estimated to be valued at USD 408.1 Bn in 2024 and is expected to reach USD 972.2 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 408.1 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 13.20% 2031 Value Projection: US$ 972.2 Bn
Figure. Life Sciences BPO Market Share (%), By Region 2024
Life Sciences BPO Market - IMG1

The life sciences BPO market comprises outsourcing services provided to pharmaceutical, biotechnology, medical device companies and others in the healthcare industry. It helps life sciences companies to focus on core activities of drug discovery, product development and commercialization. Services like regulatory affairs management, clinical data management, medical writing and publishing, pharmacovigilance, medical monitoring and other clinical trial related services are outsourced to specialized BPO players. Factors such as cost optimization, access to advanced infrastructure and expertise, complex regulatory frameworks and need to streamline operations has increased outsourcing in the life sciences sector.

Market Dynamics:

Global life sciences BPO market growth is driven by rising need for cost-optimization among life sciences companies coupled with benefits of access to advanced infrastructure and expertise delivered by BPO service providers. Moreover, regulatory frameworks for drug development and approval have become highly complex over the years, thus, necessitating outsourcing of non-core functionalities. Changing dynamics of the healthcare industry including shift towards value-based care has also prompted life sciences players to streamline their operations through strategic outsourcing. However, factors such as data security concerns, loss of control over critical functions and operational challenges associated with vendor management can hamper the market growth. Growing healthcare expenditure in developing regions, development of biosimilars & genomic drugs and integration of AI/blockchain to enhance BPO services can offer market growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global life sciences BPO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global life sciences BPO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Cognizant, Accenture, Genpact, EXL services, and Catalent

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global life sciences BPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life sciences BPO market

Detailed Segmentation-

  • By Service Type
    • Pharmaceutical outsourcing
    • Contract manufacturing market
    • API
    • Finished dose form
    • Packaging
    • Contract research organizations
    • Drug discovery
    • Preclinical studies
    • Clinical trial studies
    • Regulatory services
    • Pharmacovigilance
    • Medical devices outsourcing
    • Contract manufacturing market
    • Electronic manufacturing services
    • Finished goods
    • Raw materials/components
    • Contract research organizations
    • Regulatory consulting services
    • Product design and development services
    • Product testing services
    • Product implementation services
    • Product upgrade services
    • Product maintenance services
    • Contract sales & market outsourcing
    • Others
  • By End User
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations Medical Device Companies
    • Academic Institutes & Government Organizations
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Accenture, Plc
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab Biotechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Life Sciences BPO Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Life Sciences BPO Market, By Service Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Pharmaceutical outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
    • Contract manufacturing market
  • API
  • Finished dose form
  • Packaging
    • Contract research organizations
  • Drug discovery
  • Preclinical studies
  • Clinical trial studies
  • Regulatory services
  • Pharmacovigilance
  • Medical devices outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
    • Contract manufacturing market
  • Electronic manufacturing services
  • Finished goods
  • Raw materials/components
    • Contract research organizations
  • Regulatory consulting services
  • Product design and development services
  • Product testing services
  • Product implementation services
  • Product upgrade services
  • Product maintenance services
  • Contract sales & market outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Life Sciences BPO Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Biotechnology Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Device Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic Institutes & Government Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Life Sciences BPO Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Accenture, Plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab Biotechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact